Clinical Trial Update: The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating platelet-rich plasma nasal injections for traumatic olfactory dysfunction with anosmia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Olfactory Nerve Injury
• Traumatic Olfactory Dysfunction

Drugs mentioned

• platelet-rich plasma nasal injection

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis), Effect of Drug | Phase 3 | Status: UNKNOWN